There are alarming reports of new and emerging microbial diseases. The recent emergence of COVID-19 is a burning example that has attracted global attention. Not only this, the development of multidrug resistance in microbes is frightening and thus the available antibiotics have been ineffective. Considering these facts, there is a pressing need to develop effective treatment options that are eco-friendly, biobased, and cost-effective. The present book covers the natural/bio-based products from plants, mushrooms and microbes that can be used against different microbial diseases caused by viruses, bacteria and fungi. This book would be an essential reading for students, researchers and people from pharma industries.
Key features:
- Describes the biobased natural products to combat microbial diseases.
- Examines the antimicrobial potential of mushrooms, endophytes and secondary metabolites.
- Discusses the role of defensins and terpenes in microbial diseases.
- Incorporates natural products from the Amazon for treating microbial diseases.
About the Author: Dr. Mahendra Rai is presently a visiting Professor at the Department of Microbiology, Nicolaus Copernicus University, Torun, Poland. Formerly he was Professor and Head of department of Biotechnology, SGB Amravati University, Maharashtra state, India. He was a visiting scientist at the University of Geneva, Debrecen University, Hungary; University of Campinas, Brazil; VSB Technical University of Ostrava, Czech Republic, and National University of Rosario, Argentina, and University of Sao Paulo. He has published more than 425 research papers in national and international journals. In addition, he has edited/authored more than 62 books and 6 patents. Recently, he has been featured in Stanford's list of top 2% scientists under Nanoscience and Nanotechnology.
Dr. Chistiane M. Feitosa is a Professor at the Department of Chemistry, Federal University of Piaui, Teresina, Brazil. Her research areas include pharmacology, natural products and their secondary metabolites with the potential for treatment of neurodegenerative diseases and antimicrobials. She has published more than 55 research papers in national and international journals. In addition, she has edited/authored more than 12 books /chapters from eminent publishers like CRC press/ Taylor and Francis and also 5 patents.
